No abstract available
MeSH terms
-
Aged
-
Angiogenesis Inhibitors / therapeutic use*
-
Bevacizumab / therapeutic use*
-
Blindness / diagnosis
-
Blindness / etiology*
-
Blindness / physiopathology
-
Female
-
Glaucoma, Open-Angle / complications
-
Humans
-
Intravitreal Injections / adverse effects*
-
Macular Edema / drug therapy*
-
Macular Edema / etiology
-
Retinal Perforations / diagnostic imaging
-
Retinal Perforations / etiology*
-
Retinal Perforations / physiopathology
-
Retinal Vein Occlusion / complications
-
Retinal Vein Occlusion / drug therapy*
-
Subretinal Fluid / diagnostic imaging
-
Tomography, Optical Coherence
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / physiology
Substances
-
Angiogenesis Inhibitors
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
Bevacizumab